Debt to Equity Ratio Chart

View Debt to Equity Ratio for MMSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 0.505
December 31, 2025 0.5186
September 30, 2025 0.5369
June 30, 2025 0.5514
March 31, 2025 0.5724
December 31, 2024 0.5761
September 30, 2024 0.619
June 30, 2024 0.6792
March 31, 2024 0.7037
December 31, 2023 0.7416
September 30, 2023 0.2889
June 30, 2023 0.3382
March 31, 2023 0.2274
December 31, 2022 0.2348
September 30, 2022 0.2635
June 30, 2022 0.2945
March 31, 2022 0.3059
December 31, 2021 0.303
September 30, 2021 0.3486
June 30, 2021 0.3728
March 31, 2021 0.4102
December 31, 2020 0.4539
September 30, 2020 0.4709
June 30, 2020 0.533
March 31, 2020 0.5628
Date Value
December 31, 2019 0.5513
September 30, 2019 0.5517
June 30, 2019 0.5083
March 31, 2019 0.4981
December 31, 2018 0.4236
September 30, 2018 0.2262
June 30, 2018 0.5914
March 31, 2018 0.5614
December 31, 2017 0.4117
September 30, 2017 0.4168
June 30, 2017 0.363
March 31, 2017 0.3639
December 31, 2016 0.6511
September 30, 2016 0.6745
June 30, 2016 0.4828
March 31, 2016 0.4836
December 31, 2015 0.4454
September 30, 2015 0.4584
June 30, 2015 0.4633
March 31, 2015 0.4809
December 31, 2014 0.5158
September 30, 2014 0.5668
June 30, 2014 0.5972
March 31, 2014 0.6211
December 31, 2013 0.6134

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Cerus Corp. 1.441
Globus Medical, Inc. 0.0245
Abbott Laboratories 0.654
AngioDynamics, Inc. 0.0657
Alphatec Holdings, Inc. 33.03